The data are consistent with reports that TCP-based LSD1 inhibitors including GSK2879552, ORY-1001, IMG-7289 mainly inhibited the proliferation of AML and MDS, but not DLBCL and solid tumors. The gene discussed is KDM1A; the disease is diffuse large B-cell lymphoma.